Literature DB >> 28685925

What goes wrong with the allocation of domestic and international resources for HIV?

Olivier C Sterck1.   

Abstract

This paper examines how domestic and international financing for HIV is, and ought to be, distributed. We build a theoretical framework that decomposes domestic and international financing for HIV into nonlinear functions of national income, HIV prevalence, and government effectiveness. We test this model, paying particular attention to nonlinearities and to problems of bad controls, multicollinearity, and reverse causality. Finally, we use the fitted values of quartile regressions to study how much countries could reasonably pay domestically and how much they should receive from donors. Worryingly, countries with higher financial means receive on average more aid per PLHIV than very poor ones, and countries with higher HIV prevalence receive on average less aid per people living with HIV. The normative analysis concludes that US$3.08 billion of fiscal space could be created in LIC and MIC. We identify the countries that could be allocated more aid.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HIV/AIDS; aid; financing; government health expenditures; regression analysis

Mesh:

Year:  2017        PMID: 28685925     DOI: 10.1002/hec.3550

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  2 in total

1.  Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.

Authors:  Annie Haakenstad; Mark W Moses; Tianchan Tao; Golsum Tsakalos; Bianca Zlavog; Jennifer Kates; Adam Wexler; Christopher J L Murray; Joseph L Dieleman
Journal:  Lancet HIV       Date:  2019-04-26       Impact factor: 12.767

2.  Health priority-setting for official development assistance in low-income and middle-income countries: a Best Fit Framework Synthesis study with primary data from Ethiopia, Nigeria and Tanzania.

Authors:  Rifat Atun; Wafaie Fawzi; Xiaoxiao Jiang Kwete; Yemane Berhane; Mary Mwanyika-Sando; Ayo Oduola; Yuning Liu; Firehiwot Workneh; Smret Hagos; Japhet Killewo; Dominic Mosha; Angela Chukwu; Kabiru Salami; Bidemi Yusuf; Kun Tang; Zhi-Jie Zheng
Journal:  BMC Public Health       Date:  2021-11-21       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.